Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Status Epilepticus | 71 | 2024 | 463 | 17.960 |
Why?
|
Seizures | 108 | 2024 | 3000 | 10.570 |
Why?
|
Epilepsy | 111 | 2024 | 3326 | 10.420 |
Why?
|
Anticonvulsants | 69 | 2024 | 1923 | 7.910 |
Why?
|
Electroencephalography | 122 | 2024 | 6317 | 6.300 |
Why?
|
Brain Waves | 15 | 2021 | 418 | 3.160 |
Why?
|
Epilepsies, Partial | 14 | 2020 | 435 | 2.770 |
Why?
|
Benzodiazepines | 17 | 2024 | 1139 | 2.580 |
Why?
|
Spasms, Infantile | 15 | 2022 | 301 | 2.410 |
Why?
|
Functional Laterality | 20 | 2017 | 2268 | 2.310 |
Why?
|
Amobarbital | 12 | 2012 | 43 | 2.220 |
Why?
|
Epilepsy, Generalized | 9 | 2024 | 181 | 2.160 |
Why?
|
Sleep | 26 | 2020 | 4802 | 2.150 |
Why?
|
Child | 166 | 2024 | 80894 | 1.900 |
Why?
|
Drug Chronotherapy | 5 | 2018 | 10 | 1.810 |
Why?
|
Child, Preschool | 119 | 2024 | 42654 | 1.660 |
Why?
|
Photoplethysmography | 2 | 2020 | 66 | 1.370 |
Why?
|
Autonomic Nervous System | 6 | 2020 | 709 | 1.360 |
Why?
|
Epilepsy, Temporal Lobe | 8 | 2011 | 390 | 1.320 |
Why?
|
Infant | 96 | 2024 | 36512 | 1.310 |
Why?
|
Monitoring, Ambulatory | 6 | 2020 | 357 | 1.280 |
Why?
|
Brain | 38 | 2022 | 27452 | 1.140 |
Why?
|
Monitoring, Physiologic | 14 | 2022 | 1795 | 1.120 |
Why?
|
Circadian Rhythm | 12 | 2019 | 2588 | 1.120 |
Why?
|
Adolescent | 111 | 2024 | 89182 | 1.080 |
Why?
|
Wakefulness | 9 | 2017 | 1283 | 1.050 |
Why?
|
Diazepam | 4 | 2023 | 214 | 1.030 |
Why?
|
Humans | 291 | 2024 | 768298 | 1.020 |
Why?
|
Galvanic Skin Response | 6 | 2024 | 359 | 1.000 |
Why?
|
Triazoles | 5 | 2020 | 904 | 0.990 |
Why?
|
Brain Diseases | 5 | 2020 | 1552 | 0.970 |
Why?
|
Pediatrics | 14 | 2019 | 3624 | 0.950 |
Why?
|
Vigabatrin | 6 | 2022 | 88 | 0.920 |
Why?
|
Male | 178 | 2024 | 364870 | 0.860 |
Why?
|
Allostasis | 1 | 2024 | 77 | 0.840 |
Why?
|
Retrospective Studies | 90 | 2024 | 81768 | 0.820 |
Why?
|
Female | 178 | 2024 | 397050 | 0.800 |
Why?
|
Intensive Care Units, Pediatric | 7 | 2023 | 1024 | 0.790 |
Why?
|
Seizures, Febrile | 3 | 2021 | 109 | 0.770 |
Why?
|
Hypnotics and Sedatives | 6 | 2012 | 1188 | 0.740 |
Why?
|
Decision Support Techniques | 4 | 2020 | 2005 | 0.720 |
Why?
|
Methohexital | 3 | 2010 | 17 | 0.710 |
Why?
|
Young Adult | 65 | 2024 | 60048 | 0.680 |
Why?
|
Language | 8 | 2014 | 1558 | 0.670 |
Why?
|
Infant, Newborn | 33 | 2020 | 26410 | 0.660 |
Why?
|
Neurosurgical Procedures | 7 | 2017 | 2097 | 0.660 |
Why?
|
Cerebral Cortex | 8 | 2014 | 5830 | 0.650 |
Why?
|
Language Disorders | 3 | 2015 | 140 | 0.650 |
Why?
|
Wrist | 6 | 2024 | 232 | 0.640 |
Why?
|
Video Recording | 12 | 2021 | 974 | 0.630 |
Why?
|
Thalamus | 2 | 2017 | 1050 | 0.600 |
Why?
|
Videotape Recording | 9 | 2012 | 336 | 0.570 |
Why?
|
Sleep Stages | 3 | 2021 | 705 | 0.560 |
Why?
|
Adrenocorticotropic Hormone | 6 | 2021 | 619 | 0.560 |
Why?
|
International Classification of Diseases | 3 | 2019 | 924 | 0.560 |
Why?
|
Apnea | 2 | 2018 | 195 | 0.560 |
Why?
|
Natural Language Processing | 2 | 2023 | 1202 | 0.550 |
Why?
|
Neurology | 6 | 2018 | 786 | 0.540 |
Why?
|
Medical Informatics Applications | 1 | 2018 | 180 | 0.540 |
Why?
|
Hospitals, Pediatric | 6 | 2020 | 1876 | 0.540 |
Why?
|
Epilepsy, Tonic-Clonic | 3 | 2019 | 54 | 0.540 |
Why?
|
Receptors, Glutamate | 2 | 2014 | 229 | 0.530 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2024 | 1496 | 0.530 |
Why?
|
Memory | 5 | 2009 | 2210 | 0.530 |
Why?
|
Critical Illness | 5 | 2023 | 2755 | 0.530 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2018 | 710 | 0.520 |
Why?
|
Roseolovirus Infections | 1 | 2016 | 50 | 0.520 |
Why?
|
Herpesvirus 6, Human | 1 | 2016 | 98 | 0.510 |
Why?
|
Time Factors | 24 | 2021 | 40267 | 0.510 |
Why?
|
Death, Sudden | 5 | 2019 | 301 | 0.500 |
Why?
|
Bone Diseases | 1 | 2019 | 417 | 0.500 |
Why?
|
Disease Management | 4 | 2024 | 2536 | 0.500 |
Why?
|
Temporal Lobe | 5 | 2011 | 1728 | 0.500 |
Why?
|
Uncertainty | 1 | 2020 | 759 | 0.500 |
Why?
|
Patient Admission | 2 | 2020 | 1367 | 0.500 |
Why?
|
Encephalitis | 2 | 2013 | 441 | 0.490 |
Why?
|
Neuropsychological Tests | 12 | 2017 | 7145 | 0.490 |
Why?
|
Critical Care | 7 | 2023 | 2716 | 0.480 |
Why?
|
Terminology as Topic | 5 | 2019 | 1539 | 0.480 |
Why?
|
Hospital Administration | 1 | 2018 | 353 | 0.480 |
Why?
|
Cognition Disorders | 4 | 2019 | 3985 | 0.470 |
Why?
|
Treatment Outcome | 39 | 2021 | 65365 | 0.460 |
Why?
|
Quality Improvement | 5 | 2019 | 3858 | 0.450 |
Why?
|
Protein Subunits | 2 | 2014 | 943 | 0.440 |
Why?
|
Emergency Medical Services | 2 | 2022 | 1946 | 0.440 |
Why?
|
Language Tests | 3 | 2014 | 193 | 0.430 |
Why?
|
Nervous System Malformations | 2 | 2008 | 244 | 0.430 |
Why?
|
Databases, Factual | 7 | 2021 | 8072 | 0.420 |
Why?
|
Age of Onset | 11 | 2018 | 3345 | 0.420 |
Why?
|
Family Health | 1 | 2017 | 1255 | 0.410 |
Why?
|
Chronobiology Phenomena | 1 | 2012 | 29 | 0.410 |
Why?
|
Electronic Health Records | 7 | 2023 | 4874 | 0.410 |
Why?
|
Anesthesia | 1 | 2023 | 1596 | 0.410 |
Why?
|
Cognition | 4 | 2017 | 7074 | 0.400 |
Why?
|
Dominance, Cerebral | 3 | 2003 | 624 | 0.390 |
Why?
|
Research | 2 | 2019 | 1981 | 0.390 |
Why?
|
Receptors, GABA | 1 | 2014 | 313 | 0.390 |
Why?
|
Chronobiology Disorders | 1 | 2012 | 73 | 0.390 |
Why?
|
Statistics, Nonparametric | 10 | 2019 | 2862 | 0.380 |
Why?
|
Giant Cell Arteritis | 2 | 2007 | 307 | 0.380 |
Why?
|
Brain Mapping | 7 | 2014 | 6740 | 0.380 |
Why?
|
Electric Stimulation Therapy | 4 | 2006 | 636 | 0.380 |
Why?
|
Septo-Optic Dysplasia | 1 | 2011 | 8 | 0.370 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2019 | 862 | 0.370 |
Why?
|
Septum Pellucidum | 1 | 2011 | 55 | 0.360 |
Why?
|
Injections, Intra-Arterial | 5 | 2010 | 181 | 0.360 |
Why?
|
Phenobarbital | 4 | 2020 | 192 | 0.360 |
Why?
|
Leukomalacia, Periventricular | 1 | 2012 | 184 | 0.360 |
Why?
|
Data Collection | 4 | 2021 | 3324 | 0.360 |
Why?
|
Magnetic Resonance Imaging | 28 | 2018 | 36849 | 0.360 |
Why?
|
Drug Prescriptions | 2 | 2019 | 1673 | 0.360 |
Why?
|
Heart Rate | 8 | 2022 | 4218 | 0.350 |
Why?
|
Cost of Illness | 1 | 2020 | 1959 | 0.350 |
Why?
|
Crying | 1 | 2010 | 37 | 0.350 |
Why?
|
Arachnoid Cysts | 1 | 2011 | 60 | 0.350 |
Why?
|
Risk Factors | 23 | 2023 | 74954 | 0.340 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2010 | 46 | 0.340 |
Why?
|
Vagus Nerve Stimulation | 1 | 2013 | 229 | 0.340 |
Why?
|
Names | 1 | 2010 | 54 | 0.340 |
Why?
|
Epilepsy, Rolandic | 2 | 2021 | 57 | 0.340 |
Why?
|
Nystagmus, Pathologic | 2 | 2008 | 104 | 0.340 |
Why?
|
Anesthetics, Intravenous | 2 | 2010 | 397 | 0.340 |
Why?
|
Adult | 56 | 2024 | 223622 | 0.330 |
Why?
|
Subthalamic Nucleus | 2 | 2003 | 203 | 0.330 |
Why?
|
Sensitivity and Specificity | 13 | 2020 | 14736 | 0.310 |
Why?
|
Health Care Costs | 3 | 2018 | 3267 | 0.310 |
Why?
|
Speech | 2 | 2012 | 558 | 0.310 |
Why?
|
Brain Neoplasms | 4 | 2016 | 9197 | 0.310 |
Why?
|
Child Development | 3 | 2011 | 2334 | 0.310 |
Why?
|
Moyamoya Disease | 2 | 2011 | 274 | 0.300 |
Why?
|
Epilepsy, Frontal Lobe | 2 | 2011 | 24 | 0.300 |
Why?
|
Cost-Benefit Analysis | 3 | 2019 | 5538 | 0.300 |
Why?
|
Prospective Studies | 27 | 2023 | 54921 | 0.300 |
Why?
|
Ambulatory Care | 2 | 2019 | 2784 | 0.300 |
Why?
|
Synaptic Transmission | 1 | 2014 | 1175 | 0.300 |
Why?
|
Neurocutaneous Syndromes | 1 | 2008 | 53 | 0.300 |
Why?
|
Choice Behavior | 1 | 2014 | 848 | 0.300 |
Why?
|
Follow-Up Studies | 21 | 2019 | 39405 | 0.300 |
Why?
|
Action Potentials | 2 | 2021 | 1838 | 0.300 |
Why?
|
Patient Readmission | 2 | 2020 | 3312 | 0.300 |
Why?
|
Perceptual Disorders | 1 | 2010 | 199 | 0.300 |
Why?
|
Hospital Mortality | 4 | 2021 | 5367 | 0.300 |
Why?
|
Longitudinal Studies | 10 | 2019 | 14783 | 0.290 |
Why?
|
Electrodes | 4 | 2023 | 617 | 0.290 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8051 | 0.290 |
Why?
|
Infant, Premature | 1 | 2017 | 2125 | 0.290 |
Why?
|
Frontal Lobe | 1 | 2014 | 1428 | 0.280 |
Why?
|
Age Factors | 14 | 2020 | 18472 | 0.280 |
Why?
|
Analysis of Variance | 4 | 2017 | 6238 | 0.280 |
Why?
|
Ankle | 2 | 2020 | 354 | 0.280 |
Why?
|
Cranial Nerve Diseases | 2 | 2004 | 111 | 0.270 |
Why?
|
Malformations of Cortical Development | 1 | 2008 | 176 | 0.270 |
Why?
|
Treatment Failure | 3 | 2019 | 2664 | 0.270 |
Why?
|
Sclerosis | 3 | 2011 | 213 | 0.260 |
Why?
|
Intensive Care Units | 7 | 2019 | 3800 | 0.260 |
Why?
|
Predictive Value of Tests | 11 | 2019 | 15455 | 0.250 |
Why?
|
Cerebral Arteries | 1 | 2008 | 489 | 0.250 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.250 |
Why?
|
Electrodes, Implanted | 4 | 2013 | 841 | 0.240 |
Why?
|
Pituitary Gland | 1 | 2008 | 634 | 0.240 |
Why?
|
Patient Compliance | 3 | 2014 | 2693 | 0.240 |
Why?
|
Comparative Effectiveness Research | 1 | 2010 | 712 | 0.240 |
Why?
|
Electrocardiography | 6 | 2020 | 6409 | 0.240 |
Why?
|
Piloerection | 1 | 2004 | 5 | 0.240 |
Why?
|
Baclofen | 1 | 2005 | 120 | 0.230 |
Why?
|
Algorithms | 9 | 2023 | 14154 | 0.230 |
Why?
|
Hemiplegia | 2 | 2004 | 137 | 0.230 |
Why?
|
Perioperative Care | 1 | 2012 | 1045 | 0.230 |
Why?
|
Body Temperature | 2 | 2020 | 781 | 0.230 |
Why?
|
Lipoma | 1 | 2006 | 296 | 0.230 |
Why?
|
Telemedicine | 2 | 2018 | 3107 | 0.220 |
Why?
|
Cohort Studies | 21 | 2021 | 41791 | 0.220 |
Why?
|
Optic Disk | 1 | 2008 | 422 | 0.220 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2024 | 10776 | 0.220 |
Why?
|
Hemispherectomy | 1 | 2004 | 41 | 0.220 |
Why?
|
Developmental Disabilities | 4 | 2020 | 1516 | 0.210 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2004 | 145 | 0.210 |
Why?
|
Societies, Medical | 2 | 2018 | 3960 | 0.210 |
Why?
|
London | 1 | 2023 | 233 | 0.210 |
Why?
|
Periodicity | 2 | 2016 | 348 | 0.210 |
Why?
|
Prognosis | 10 | 2022 | 30020 | 0.210 |
Why?
|
Visual Perception | 2 | 2014 | 1406 | 0.200 |
Why?
|
Practice Guidelines as Topic | 6 | 2020 | 7453 | 0.200 |
Why?
|
Case-Control Studies | 7 | 2023 | 22292 | 0.200 |
Why?
|
Carotid Artery Injuries | 1 | 2002 | 96 | 0.200 |
Why?
|
Psychophysiologic Disorders | 3 | 2015 | 223 | 0.200 |
Why?
|
Tooth Abnormalities | 1 | 2002 | 56 | 0.200 |
Why?
|
Phenytoin | 2 | 2020 | 190 | 0.200 |
Why?
|
Aphasia | 1 | 2004 | 193 | 0.200 |
Why?
|
Language Development | 1 | 2003 | 184 | 0.190 |
Why?
|
United States | 21 | 2023 | 73144 | 0.190 |
Why?
|
Syndrome | 5 | 2012 | 3275 | 0.190 |
Why?
|
Brain Damage, Chronic | 1 | 2022 | 267 | 0.190 |
Why?
|
Urination | 1 | 2003 | 203 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3412 | 0.190 |
Why?
|
Attitude to Health | 1 | 2010 | 2025 | 0.190 |
Why?
|
Fear | 1 | 2010 | 1494 | 0.190 |
Why?
|
Automatism | 3 | 2005 | 10 | 0.190 |
Why?
|
Logistic Models | 7 | 2019 | 13323 | 0.190 |
Why?
|
Hand Deformities, Congenital | 1 | 2002 | 175 | 0.180 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2002 | 370 | 0.180 |
Why?
|
Middle Aged | 34 | 2024 | 223463 | 0.180 |
Why?
|
Magnetic Resonance Angiography | 4 | 2009 | 1434 | 0.180 |
Why?
|
Sodium Channel Blockers | 2 | 2022 | 173 | 0.180 |
Why?
|
Entropy | 1 | 2021 | 212 | 0.180 |
Why?
|
Monte Carlo Method | 2 | 2017 | 1260 | 0.180 |
Why?
|
Executive Function | 1 | 2009 | 1405 | 0.180 |
Why?
|
Pulse | 1 | 2020 | 218 | 0.180 |
Why?
|
Disease Progression | 5 | 2024 | 13646 | 0.180 |
Why?
|
Quality of Life | 3 | 2018 | 13499 | 0.170 |
Why?
|
Substantia Nigra | 1 | 2001 | 348 | 0.170 |
Why?
|
Vision Disorders | 1 | 2007 | 1093 | 0.170 |
Why?
|
Eye Abnormalities | 1 | 2002 | 243 | 0.170 |
Why?
|
Adrenal Cortex Hormones | 3 | 2016 | 1890 | 0.170 |
Why?
|
Pentobarbital | 2 | 2017 | 153 | 0.170 |
Why?
|
Midazolam | 2 | 2021 | 267 | 0.160 |
Why?
|
Peripheral Nervous System | 1 | 2020 | 151 | 0.160 |
Why?
|
Drug Therapy, Combination | 5 | 2017 | 6319 | 0.160 |
Why?
|
Ketamine | 2 | 2017 | 524 | 0.160 |
Why?
|
Guideline Adherence | 2 | 2020 | 2240 | 0.160 |
Why?
|
Health Care Surveys | 2 | 2019 | 2437 | 0.160 |
Why?
|
Cerebellum | 1 | 2006 | 1514 | 0.160 |
Why?
|
Spasm | 2 | 2012 | 131 | 0.160 |
Why?
|
Constipation | 1 | 2003 | 570 | 0.160 |
Why?
|
Motor Cortex | 2 | 2004 | 1014 | 0.160 |
Why?
|
Linear Models | 2 | 2020 | 5878 | 0.150 |
Why?
|
Preoperative Care | 3 | 2014 | 2257 | 0.150 |
Why?
|
Forecasting | 2 | 2020 | 2948 | 0.150 |
Why?
|
Photoperiod | 1 | 2019 | 141 | 0.150 |
Why?
|
Consensus | 2 | 2018 | 3212 | 0.150 |
Why?
|
Sodium Channels | 1 | 2019 | 341 | 0.150 |
Why?
|
Kv1.2 Potassium Channel | 1 | 2017 | 16 | 0.150 |
Why?
|
Diagnosis, Differential | 8 | 2017 | 13019 | 0.140 |
Why?
|
Subdural Space | 2 | 2014 | 38 | 0.140 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2020 | 1482 | 0.140 |
Why?
|
Polysomnography | 3 | 2013 | 1865 | 0.140 |
Why?
|
Drug Administration Routes | 1 | 2017 | 151 | 0.140 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2017 | 19 | 0.140 |
Why?
|
Educational Status | 2 | 2023 | 2518 | 0.140 |
Why?
|
Reproducibility of Results | 11 | 2024 | 20224 | 0.140 |
Why?
|
Clinical Protocols | 2 | 2015 | 1445 | 0.140 |
Why?
|
Self-Assessment | 2 | 2010 | 401 | 0.140 |
Why?
|
Retina | 1 | 2008 | 2661 | 0.140 |
Why?
|
Aged | 22 | 2020 | 171544 | 0.140 |
Why?
|
Sex Factors | 4 | 2020 | 10656 | 0.140 |
Why?
|
Movement | 1 | 2023 | 1490 | 0.140 |
Why?
|
Actigraphy | 1 | 2020 | 526 | 0.130 |
Why?
|
Databases, Bibliographic | 1 | 2016 | 129 | 0.130 |
Why?
|
Prevalence | 4 | 2022 | 15868 | 0.130 |
Why?
|
Valproic Acid | 1 | 2019 | 443 | 0.130 |
Why?
|
Aging | 4 | 2024 | 8764 | 0.130 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2017 | 88 | 0.130 |
Why?
|
Hospitalization | 7 | 2018 | 10844 | 0.130 |
Why?
|
Potassium Channels | 1 | 2018 | 538 | 0.130 |
Why?
|
Motor Activity | 3 | 2011 | 2720 | 0.120 |
Why?
|
Respiratory Mechanics | 1 | 2019 | 722 | 0.120 |
Why?
|
Drug Resistance | 5 | 2019 | 1595 | 0.120 |
Why?
|
Nerve Net | 2 | 2019 | 2362 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2013 | 10377 | 0.120 |
Why?
|
Risk Assessment | 3 | 2015 | 24316 | 0.120 |
Why?
|
Receptors, Neurotransmitter | 1 | 2015 | 174 | 0.120 |
Why?
|
Carotid Artery, Internal | 2 | 2008 | 445 | 0.120 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2014 | 59 | 0.120 |
Why?
|
Benchmarking | 1 | 2021 | 1058 | 0.120 |
Why?
|
Emergency Treatment | 1 | 2018 | 496 | 0.120 |
Why?
|
Odds Ratio | 3 | 2017 | 9681 | 0.110 |
Why?
|
Incidence | 5 | 2015 | 21544 | 0.110 |
Why?
|
Databases as Topic | 1 | 2016 | 475 | 0.110 |
Why?
|
Area Under Curve | 1 | 2018 | 1642 | 0.110 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2014 | 40 | 0.110 |
Why?
|
Emergency Service, Hospital | 4 | 2018 | 7955 | 0.110 |
Why?
|
Multivariate Analysis | 5 | 2020 | 12092 | 0.110 |
Why?
|
North America | 2 | 2014 | 1290 | 0.110 |
Why?
|
Vital Signs | 1 | 2014 | 144 | 0.110 |
Why?
|
Food-Drug Interactions | 1 | 2013 | 26 | 0.110 |
Why?
|
Neural Pathways | 3 | 2011 | 3121 | 0.110 |
Why?
|
Research Design | 5 | 2021 | 6209 | 0.110 |
Why?
|
Biotransformation | 1 | 2013 | 166 | 0.110 |
Why?
|
Angiomatosis | 1 | 2013 | 46 | 0.110 |
Why?
|
Wavelet Analysis | 1 | 2013 | 56 | 0.110 |
Why?
|
Lysosomes | 1 | 2018 | 939 | 0.100 |
Why?
|
Leukocytosis | 1 | 2014 | 250 | 0.100 |
Why?
|
Sleep Medicine Specialty | 1 | 2013 | 72 | 0.100 |
Why?
|
Consciousness Disorders | 1 | 2017 | 445 | 0.100 |
Why?
|
Muscle Spasticity | 2 | 2005 | 159 | 0.100 |
Why?
|
Kinetocardiography | 1 | 2012 | 6 | 0.100 |
Why?
|
Health Services Accessibility | 1 | 2010 | 5511 | 0.100 |
Why?
|
Age Distribution | 1 | 2018 | 2877 | 0.100 |
Why?
|
Carotid Arteries | 2 | 2009 | 943 | 0.100 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 875 | 0.100 |
Why?
|
Nervous System Diseases | 2 | 2013 | 1664 | 0.100 |
Why?
|
Audiovisual Aids | 1 | 2013 | 99 | 0.100 |
Why?
|
Spain | 1 | 2013 | 492 | 0.100 |
Why?
|
Animals | 9 | 2023 | 169322 | 0.100 |
Why?
|
Lobosea | 1 | 2011 | 2 | 0.100 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2014 | 452 | 0.100 |
Why?
|
Central Nervous System Protozoal Infections | 1 | 2011 | 6 | 0.100 |
Why?
|
Quality Assurance, Health Care | 2 | 2013 | 2180 | 0.100 |
Why?
|
Intestinal Absorption | 1 | 2013 | 400 | 0.100 |
Why?
|
Poverty | 1 | 2024 | 2721 | 0.100 |
Why?
|
Sturge-Weber Syndrome | 1 | 2013 | 89 | 0.100 |
Why?
|
Hippocampus | 3 | 2010 | 3784 | 0.100 |
Why?
|
Organ Size | 1 | 2017 | 2268 | 0.100 |
Why?
|
Conversion Disorder | 1 | 2015 | 202 | 0.100 |
Why?
|
Pharmacogenetics | 1 | 2016 | 683 | 0.100 |
Why?
|
Scalp | 1 | 2014 | 391 | 0.090 |
Why?
|
Delivery of Health Care | 3 | 2018 | 5375 | 0.090 |
Why?
|
Outpatients | 2 | 2018 | 1603 | 0.090 |
Why?
|
Chromosome Disorders | 1 | 2014 | 499 | 0.090 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2011 | 52 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7861 | 0.090 |
Why?
|
Airway Management | 1 | 2014 | 326 | 0.090 |
Why?
|
Cadherins | 1 | 2016 | 905 | 0.090 |
Why?
|
Physical Examination | 1 | 2017 | 1262 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.090 |
Why?
|
Meningoencephalitis | 1 | 2011 | 83 | 0.090 |
Why?
|
Postoperative Period | 2 | 2008 | 1830 | 0.090 |
Why?
|
Shock, Hemorrhagic | 1 | 2012 | 224 | 0.090 |
Why?
|
Markov Chains | 1 | 2014 | 977 | 0.090 |
Why?
|
Caregivers | 1 | 2023 | 2303 | 0.090 |
Why?
|
Fluid Therapy | 1 | 2014 | 585 | 0.090 |
Why?
|
Triage | 1 | 2017 | 994 | 0.090 |
Why?
|
Motion | 1 | 2014 | 789 | 0.090 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1315 | 0.090 |
Why?
|
Autophagy | 1 | 2018 | 1350 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2017 | 3579 | 0.090 |
Why?
|
Phenotype | 5 | 2021 | 16716 | 0.090 |
Why?
|
Conductometry | 1 | 2010 | 10 | 0.090 |
Why?
|
Medical History Taking | 2 | 2012 | 776 | 0.090 |
Why?
|
Epilepsies, Myoclonic | 1 | 2011 | 85 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3826 | 0.090 |
Why?
|
Head Movements | 1 | 2011 | 153 | 0.090 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2013 | 340 | 0.090 |
Why?
|
Receptors, GABA-A | 1 | 2014 | 625 | 0.090 |
Why?
|
Occipital Lobe | 1 | 2012 | 376 | 0.090 |
Why?
|
Amygdala | 1 | 2018 | 1382 | 0.080 |
Why?
|
Phototherapy | 1 | 2013 | 367 | 0.080 |
Why?
|
Angelman Syndrome | 1 | 2012 | 139 | 0.080 |
Why?
|
Corpus Callosum | 1 | 2014 | 754 | 0.080 |
Why?
|
Stroke | 1 | 2012 | 9742 | 0.080 |
Why?
|
International Cooperation | 1 | 2016 | 1438 | 0.080 |
Why?
|
Epilepsy, Absence | 1 | 2009 | 50 | 0.080 |
Why?
|
Gliosis | 1 | 2010 | 246 | 0.080 |
Why?
|
Delayed Diagnosis | 1 | 2013 | 469 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59683 | 0.080 |
Why?
|
Consciousness | 1 | 2015 | 602 | 0.080 |
Why?
|
Acetamides | 1 | 2011 | 260 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1094 | 0.080 |
Why?
|
Granuloma | 1 | 2011 | 329 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 26373 | 0.080 |
Why?
|
Reference Standards | 1 | 2012 | 1013 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2661 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2003 | 2893 | 0.080 |
Why?
|
Biopsy | 2 | 2013 | 6808 | 0.080 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2012 | 1891 | 0.080 |
Why?
|
Brain Injuries | 1 | 2020 | 2059 | 0.080 |
Why?
|
Ohio | 1 | 2009 | 328 | 0.080 |
Why?
|
Patient Care Team | 2 | 2018 | 2529 | 0.070 |
Why?
|
Epidural Abscess | 1 | 2009 | 94 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2017 | 1240 | 0.070 |
Why?
|
Melatonin | 1 | 2013 | 669 | 0.070 |
Why?
|
Sequence Deletion | 1 | 2012 | 1496 | 0.070 |
Why?
|
Retinal Artery | 1 | 2008 | 109 | 0.070 |
Why?
|
Third Ventricle | 1 | 2008 | 75 | 0.070 |
Why?
|
Attention | 1 | 2018 | 2425 | 0.070 |
Why?
|
Genetic Testing | 2 | 2017 | 3587 | 0.070 |
Why?
|
Length of Stay | 2 | 2020 | 6516 | 0.070 |
Why?
|
Optic Nerve | 1 | 2011 | 571 | 0.070 |
Why?
|
Intelligence | 1 | 2012 | 929 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 2010 | 521 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2931 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 937 | 0.070 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2006 | 33 | 0.070 |
Why?
|
Echo-Planar Imaging | 1 | 2011 | 669 | 0.070 |
Why?
|
Neuronal Plasticity | 3 | 2004 | 1448 | 0.070 |
Why?
|
Middle Cerebral Artery | 1 | 2008 | 273 | 0.070 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2011 | 579 | 0.070 |
Why?
|
Barbiturates | 1 | 2006 | 113 | 0.070 |
Why?
|
Models, Neurological | 1 | 2014 | 1783 | 0.070 |
Why?
|
Professional-Family Relations | 1 | 2010 | 501 | 0.070 |
Why?
|
Analgesics | 1 | 2013 | 1070 | 0.070 |
Why?
|
Amnesia | 1 | 2008 | 258 | 0.070 |
Why?
|
Otolaryngology | 1 | 2013 | 701 | 0.060 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2009 | 366 | 0.060 |
Why?
|
Patients | 1 | 2012 | 909 | 0.060 |
Why?
|
Hospitals | 1 | 2019 | 3905 | 0.060 |
Why?
|
Papilledema | 1 | 2007 | 130 | 0.060 |
Why?
|
Temporal Arteries | 1 | 2007 | 155 | 0.060 |
Why?
|
Curriculum | 2 | 2023 | 3775 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2012 | 661 | 0.060 |
Why?
|
Atrophy | 2 | 2013 | 1648 | 0.060 |
Why?
|
Radiography | 2 | 2013 | 6993 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1006 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2046 | 0.060 |
Why?
|
Hypoglycemia | 1 | 2012 | 894 | 0.060 |
Why?
|
Sleep Apnea Syndromes | 1 | 2013 | 982 | 0.060 |
Why?
|
Mutation | 6 | 2022 | 30230 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2013 | 1841 | 0.060 |
Why?
|
History, Medieval | 1 | 2004 | 62 | 0.060 |
Why?
|
Synapses | 1 | 2014 | 1766 | 0.060 |
Why?
|
Graves Disease | 1 | 2006 | 239 | 0.060 |
Why?
|
GABA Agonists | 1 | 2005 | 106 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2011 | 950 | 0.060 |
Why?
|
Electric Stimulation | 2 | 2014 | 1743 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3230 | 0.060 |
Why?
|
Injections, Spinal | 1 | 2005 | 318 | 0.060 |
Why?
|
Artifacts | 2 | 2011 | 1930 | 0.060 |
Why?
|
History, Ancient | 1 | 2004 | 213 | 0.060 |
Why?
|
Infusion Pumps | 1 | 2005 | 163 | 0.060 |
Why?
|
Paresis | 1 | 2005 | 177 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2009 | 1274 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2226 | 0.060 |
Why?
|
GABA Modulators | 1 | 2004 | 109 | 0.050 |
Why?
|
Regression Analysis | 2 | 2012 | 6350 | 0.050 |
Why?
|
Vagus Nerve | 1 | 2006 | 460 | 0.050 |
Why?
|
Health Education | 1 | 2010 | 1057 | 0.050 |
Why?
|
Occult Blood | 1 | 2004 | 199 | 0.050 |
Why?
|
Administration, Rectal | 1 | 2023 | 69 | 0.050 |
Why?
|
Neurologic Examination | 3 | 2013 | 916 | 0.050 |
Why?
|
Canada | 2 | 2023 | 2139 | 0.050 |
Why?
|
Stereotyped Behavior | 1 | 2003 | 135 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2013 | 1189 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 1813 | 0.050 |
Why?
|
Inflammation | 1 | 2023 | 10863 | 0.050 |
Why?
|
Sample Size | 1 | 2006 | 848 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9433 | 0.050 |
Why?
|
Wechsler Scales | 1 | 2003 | 258 | 0.050 |
Why?
|
Ischemic Attack, Transient | 1 | 2008 | 877 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20766 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2011 | 1515 | 0.050 |
Why?
|
Defecation | 1 | 2003 | 191 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2012 | 1902 | 0.050 |
Why?
|
History, 19th Century | 1 | 2004 | 715 | 0.050 |
Why?
|
Skin | 2 | 2020 | 4499 | 0.050 |
Why?
|
Severity of Illness Index | 5 | 2017 | 15939 | 0.050 |
Why?
|
Patient Selection | 2 | 2011 | 4265 | 0.050 |
Why?
|
Nipecotic Acids | 1 | 2001 | 36 | 0.050 |
Why?
|
Genotype | 2 | 2017 | 13038 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2236 | 0.050 |
Why?
|
Decision Making | 2 | 2018 | 3953 | 0.050 |
Why?
|
Manikins | 1 | 2023 | 254 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2721 | 0.050 |
Why?
|
Urodynamics | 1 | 2003 | 348 | 0.050 |
Why?
|
Posture | 1 | 2005 | 956 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2009 | 1895 | 0.050 |
Why?
|
Inpatients | 1 | 2012 | 2569 | 0.050 |
Why?
|
Physicians | 3 | 2013 | 4614 | 0.040 |
Why?
|
Magnetics | 1 | 2003 | 599 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2013 | 3627 | 0.040 |
Why?
|
Internet | 1 | 2012 | 3107 | 0.040 |
Why?
|
Staphylococcal Infections | 1 | 2009 | 1398 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2006 | 2106 | 0.040 |
Why?
|
Homeostasis | 1 | 2011 | 3349 | 0.040 |
Why?
|
Premature Birth | 1 | 2012 | 1814 | 0.040 |
Why?
|
ROC Curve | 2 | 2020 | 3622 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 2003 | 465 | 0.040 |
Why?
|
Landau-Kleffner Syndrome | 1 | 2019 | 10 | 0.040 |
Why?
|
Postoperative Complications | 3 | 2011 | 15854 | 0.040 |
Why?
|
Sepsis | 1 | 2012 | 2601 | 0.040 |
Why?
|
Awareness | 1 | 2003 | 653 | 0.040 |
Why?
|
History, 21st Century | 1 | 2004 | 1575 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 2004 | 819 | 0.040 |
Why?
|
Electroconvulsive Therapy | 1 | 2003 | 502 | 0.040 |
Why?
|
HIV Infections | 1 | 2004 | 17575 | 0.040 |
Why?
|
Residential Facilities | 1 | 2017 | 41 | 0.040 |
Why?
|
Biomedical Research | 1 | 2013 | 3464 | 0.040 |
Why?
|
Neural Inhibition | 1 | 2001 | 588 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2006 | 8562 | 0.040 |
Why?
|
Social Behavior Disorders | 1 | 2017 | 100 | 0.040 |
Why?
|
Visual Acuity | 1 | 2007 | 2714 | 0.040 |
Why?
|
Primary Health Care | 1 | 2013 | 4748 | 0.030 |
Why?
|
Mental Disorders | 1 | 2016 | 6876 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2005 | 2056 | 0.030 |
Why?
|
Prednisolone | 1 | 2017 | 327 | 0.030 |
Why?
|
History, 20th Century | 1 | 2004 | 2771 | 0.030 |
Why?
|
Red Cross | 1 | 2016 | 12 | 0.030 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2002 | 953 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3541 | 0.030 |
Why?
|
Cerebral Palsy | 1 | 2020 | 479 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 417 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3707 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9512 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11914 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 18047 | 0.030 |
Why?
|
Denmark | 1 | 2017 | 779 | 0.030 |
Why?
|
Intracranial Aneurysm | 1 | 2004 | 1293 | 0.030 |
Why?
|
Arousal | 2 | 2015 | 1183 | 0.030 |
Why?
|
Acute Disease | 1 | 2005 | 7242 | 0.030 |
Why?
|
Rest | 1 | 2019 | 951 | 0.030 |
Why?
|
Evoked Potentials | 2 | 2014 | 1058 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1620 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2234 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5948 | 0.030 |
Why?
|
Emotions | 1 | 2005 | 2768 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5451 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2022 | 2741 | 0.030 |
Why?
|
Circadian Clocks | 1 | 2015 | 168 | 0.030 |
Why?
|
Recurrence | 2 | 2017 | 8501 | 0.030 |
Why?
|
Plethysmography | 1 | 2013 | 173 | 0.030 |
Why?
|
Data Mining | 1 | 2018 | 560 | 0.030 |
Why?
|
Aggression | 1 | 2017 | 750 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2006 | 2587 | 0.030 |
Why?
|
Pilot Projects | 1 | 2006 | 8730 | 0.030 |
Why?
|
Neurosurgery | 1 | 2019 | 690 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2006 | 12457 | 0.020 |
Why?
|
Knowledge | 1 | 2013 | 179 | 0.020 |
Why?
|
Diethylcarbamazine | 1 | 2010 | 23 | 0.020 |
Why?
|
Self-Injurious Behavior | 1 | 2017 | 568 | 0.020 |
Why?
|
Bradycardia | 1 | 2013 | 305 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2014 | 4076 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1378 | 0.020 |
Why?
|
Preoperative Period | 1 | 2013 | 563 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4545 | 0.020 |
Why?
|
Thrombosis | 1 | 2004 | 2955 | 0.020 |
Why?
|
Piracetam | 1 | 2010 | 88 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2010 | 118 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4859 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1605 | 0.020 |
Why?
|
Paralysis | 1 | 2011 | 250 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2020 | 2258 | 0.020 |
Why?
|
Oximetry | 1 | 2013 | 462 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2005 | 3247 | 0.020 |
Why?
|
Auditory Perception | 1 | 2014 | 588 | 0.020 |
Why?
|
Time | 1 | 2011 | 546 | 0.020 |
Why?
|
Clothing | 1 | 2010 | 96 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2019 | 2708 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2018 | 1839 | 0.020 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2009 | 39 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2010 | 408 | 0.020 |
Why?
|
Gestational Age | 1 | 2018 | 3615 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2005 | 6670 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1177 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1727 | 0.020 |
Why?
|
Cerebral Revascularization | 1 | 2011 | 263 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1585 | 0.020 |
Why?
|
Palliative Care | 1 | 2003 | 3643 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4043 | 0.020 |
Why?
|
Self Concept | 1 | 2013 | 1047 | 0.020 |
Why?
|
Probability | 1 | 2013 | 2482 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 848 | 0.020 |
Why?
|
Hypertension | 1 | 2007 | 8615 | 0.020 |
Why?
|
Reaction Time | 1 | 2013 | 2103 | 0.020 |
Why?
|
Mice | 1 | 2013 | 82004 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3794 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12557 | 0.020 |
Why?
|
International Agencies | 1 | 2006 | 245 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5099 | 0.020 |
Why?
|
Sex Offenses | 1 | 2010 | 358 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5916 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9371 | 0.010 |
Why?
|
Amenorrhea | 1 | 2006 | 484 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4339 | 0.010 |
Why?
|
Family | 1 | 2013 | 3208 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2008 | 1476 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3529 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2005 | 2298 | 0.010 |
Why?
|
Somatoform Disorders | 1 | 2004 | 425 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2009 | 2353 | 0.010 |
Why?
|
Image Enhancement | 1 | 2011 | 2894 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4449 | 0.010 |
Why?
|
Parents | 1 | 2013 | 3596 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 1885 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3921 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 9063 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3411 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9508 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9380 | 0.010 |
Why?
|
Lung | 1 | 2013 | 10087 | 0.010 |
Why?
|
Glucose | 1 | 2005 | 4354 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 5311 | 0.010 |
Why?
|
Survival Analysis | 1 | 2001 | 10117 | 0.000 |
Why?
|